Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- MCAP.ST
- Price
- 370.50
- Stock movement up
- +11.50 (3.20%)
- Company name
- MedCap AB (publ)
- Exchange
- (ST ,
- Currency
- SEK )
- Sector
- Healthcare >Medical Devices
- Market cap
- 5.49B
- Ent value
- 5.89B
- Price/Sales
- 3.07
- Price/Book
- 4.58
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- 24.07
- Forward P/E
- -
- PEG
- -
- EPS growth
- 203.92%
- 1 year return
- -9.96%
- 3 year return
- 30.58%
- 5 year return
- 14.98%
- 10 year return
- 29.94%
Last updated: 2025-04-15
DIVIDENDS
MCAP.ST does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | 24.07 |
| Price to OCF | 17.80 |
| Price to FCF | 21.91 |
| Price to EBITDA | 13.86 |
| EV to EBITDA | 14.89 |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 3.07 |
| Price to Book | 4.58 |
| EV to Sales | 3.29 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 14.81M |
| EPS (TTM) | 15.24 |
| FCF per share (TTM) | 16.74 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 1.79B |
| Gross profit (TTM) | 652.70M |
| Operating income (TTM) | 281.70M |
| Net income (TTM) | 227.90M |
| EPS (TTM) | 15.24 |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | 36.48% |
| Operating margin (TTM) | 15.75% |
| Profit margin (TTM) | 12.74% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 287.70M |
| Net receivables | 319.10M |
| Total current assets | 873.60M |
| Goodwill | 342.80M |
| Intangible assets | 287.90M |
| Property, plant and equipment | 382.60M |
| Total assets | 1.89B |
| Accounts payable | 238.60M |
| Short/Current long term debt | 347.50M |
| Total current liabilities | 331.90M |
| Total liabilities | 696.10M |
| Shareholder's equity | 1.20B |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | 308.20M |
| Capital expenditures (TTM) | 57.80M |
| Free cash flow (TTM) | 250.40M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | 19.02% |
| Return on Assets | 12.03% |
| Return on Invested Capital | 17.48% |
| Cash Return on Invested Capital | 19.21% |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 360.00 |
| Daily high | 370.50 |
| Daily low | 353.00 |
| Daily Volume | 25K |
| All-time high | 625.00 |
| 1y analyst estimate | 535.00 |
| Beta | 0.70 |
| EPS (TTM) | 15.24 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | 29 Apr 2025 |
Downside potential
Loading...
Downside potential data
| MCAP.ST | S&P500 | |
| Current price drop from All-time high | -40.72% | -12.04% |
| Highest price drop | -73.44% | -56.47% |
| Date of highest drop | 6 Apr 2009 | 9 Mar 2009 |
| Avg drop from high | -22.65% | -11.07% |
| Avg time to new high | 20 days | 12 days |
| Max time to new high | 963 days | 1805 days |
COMPANY DETAILS
Marketcap
5.49B
Marketcap category
Mid-cap
Description
MedCap AB (publ) is a private equity firm specializing in investments in secondary direct, later stage, industry consolidation, add-on acquisitions, growth capital, middle market, mature, turnarounds, buyout. It prefers to invest in healthcare equipment and services, biotechnology, life sciences, pharmaceuticals, med tech and assistive tech companies. The firm prefers to invest in small to medium size companies that are not listed on the stock exchange and are based in Nordic region and Northern Europe. It typically invests between SEK25 million ($2.75 million) and SEK150 million ($16.51 million) with enterprise value SEK50 million ($5.90 million) and SEK250 million ($23.06 million) and sales revenue between "5 million ($5.43 million) and "25 million ($27.18 million) and EBITDA between SEK1 million ($0.11 million) and SEK50 million ($5.50 million). The firm takes minority and majority stake. It uses its capital and loans and makes balance sheet investments. MedCap AB (publ) was founded in 2001 and is based in Stockholm, Sweden.
Employees
534
Website
Investor relations
-
SEC filings
CEO
Country
Sweden
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
As European markets navigate the turbulence caused by higher-than-expected U.S. trade tariffs, key indices like the STOXX Europe 600 have experienced their steepest declines in five years. Amidst this...
April 7, 2025
As European markets navigate a challenging landscape marked by fresh U.S. trade tariffs and fluctuating economic indicators, investors are increasingly on the lookout for resilient opportunities withi...
April 3, 2025
As European markets continue their longest streak of weekly gains since 2012, driven by encouraging company results and resilience in defense stocks, small-cap investors are navigating a landscape mar...
March 7, 2025
In a week marked by volatility, global markets have faced significant challenges, with U.S. stocks experiencing declines amid AI competition concerns and tariff risks, while European indices reached r...
February 6, 2025
As global markets react to recent political developments and economic indicators, small-cap stocks have been overshadowed by their larger counterparts, with major indexes like the S&P 500 reaching rec...
January 31, 2025
As global markets navigate a landscape marked by interest rate adjustments and mixed economic signals, small-cap stocks have faced notable challenges, with the Russell 2000 Index underperforming large...
December 16, 2024
As the European markets experience a boost from consecutive interest rate cuts by the European Central Bank, investor sentiment in Sweden is also being influenced by these broader economic shifts. In ...
October 21, 2024
As global markets experience mixed performances, small-cap stocks continue to outpace their larger counterparts, drawing investor attention. In this dynamic landscape, identifying promising opportunit...
August 2, 2024
As global markets continue to show mixed performances, with small-cap and value shares outpacing large-cap growth stocks, investors are increasingly looking towards under-the-radar opportunities. In t...
August 1, 2024